The global therapeutic drug monitoring market is poised for significant expansion, with projections indicating a rise from USD 1,203.9 million in 2024 to an impressive USD 2,527.9 million by 2034.
The instrument is used for advanced immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization applications.
The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...
Medical Device Network on MSN4d
Roche Diagnostics supports UK eye cancer AI initiativeRoche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...
The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...
Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Disease International, As of June 2024, it is anticipated that more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback